trilostane has been researched along with Pituitary ACTH Hypersecretion in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva Mello, FP; da Silva, CC; de Carvalho, GLC; de Faria Valle, S; de Moura Martins, FS; Furtado, PV; Machado, L; Meirelles, L; Neto, WS; Pöppl, ÁG | 1 |
| Arenas Bermejo, C; C Feldman, E; García San José, P; Llauet, L; Melián, C; Pérez Alenza, D; Pérez-López, L | 1 |
| Atsumi, T; Cho, KY; Inoshita, N; Kamada, K; Kameda, H; Kenmotsu, Y; Konno, S; Miyoshi, H; Nakakubo, S; Nakamura, A; Nakamura, J; Nomoto, H; Sawamura, Y; Shimatsu, A; Sugino, H; Suzuki, M; Takahashi, Y; Yamashita, Y; Yuno, A | 1 |
| Blois, S; Lemetayer, J | 1 |
| Boretti, FS; Braun, C; Reusch, CE; Sieber-Ruckstuhl, NS | 1 |
| Aste, G; Bergamini, PF; Boari, A; Corradini, S; Dondi, F; Floriano, D; Fracassi, F; Pietra, M | 1 |
| Bugbee, AC; Creevy, KE; Woolcock, AD | 1 |
| Koyama, H; Matsumoto, H; Okusa, T; Teshima, T; Uchiyama, R | 1 |
| Han, SM; Jeon, KO; Kim, HT; Kim, KH; Li, Q; Park, SC; Ryu, MO; Song, WJ; Youn, HY | 1 |
| Buijtels, JJCWM; Galac, S; Kooistra, HS; Mol, JA | 1 |
| Hara, Y; Harada, Y; Ishino, H; Koyama, H; Nezu, Y; Osamura, RY; Sako, T; Tagawa, M; Takekoshi, S; Tanaka, S; Teramoto, A; Teshima, T; Yogo, T | 1 |
1 review(s) available for trilostane and Pituitary ACTH Hypersecretion
| Article | Year |
|---|---|
Update on the use of trilostane in dogs.
Topics: Adrenocortical Hyperfunction; Alopecia; Animals; Dihydrotestosterone; Dog Diseases; Dogs; Enzyme Inhibitors; Pituitary ACTH Hypersecretion | 2018 |
1 trial(s) available for trilostane and Pituitary ACTH Hypersecretion
| Article | Year |
|---|---|
Assessment of selegiline and trilostane combined therapy efficacy for canine pituitary-dependent hypercortisolism treatment: A pilot randomized clinical trial.
Topics: Adrenocorticotropic Hormone; Animals; Cushing Syndrome; Dihydrotestosterone; Dog Diseases; Dogs; Hydrocortisone; Pilot Projects; Pituitary ACTH Hypersecretion; Selegiline | 2022 |
9 other study(ies) available for trilostane and Pituitary ACTH Hypersecretion
| Article | Year |
|---|---|
Laboratory assessment of trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism.
Topics: Adrenocorticotropic Hormone; Animals; Dihydrotestosterone; Dog Diseases; Dogs; Enzyme Inhibitors; Female; Hydrocortisone; Male; Pituitary ACTH Hypersecretion; Prospective Studies; Specific Gravity; Urine | 2020 |
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Amides; Benzamidines; Combined Modality Therapy; COVID-19; Dihydrotestosterone; Disease Progression; Female; Guanidines; Health Personnel; Heparin; Humans; Japan; Metyrapone; Neurosurgical Procedures; Pituitary ACTH Hypersecretion; Pregnenediones; Pyrazines; SARS-CoV-2; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Comparison of two treatment regimens with trilostane in dogs with pituitary-dependent hyperadrenocorticism.
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Body Weight; Dihydrotestosterone; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hydrocortisone; Male; Pituitary ACTH Hypersecretion; Retrospective Studies | 2013 |
Prognostic factors for survival in dogs with pituitary-dependent hypercortisolism treated with trilostane.
Topics: Animals; Dihydrotestosterone; Dog Diseases; Dogs; Enzyme Inhibitors; Female; Male; Pituitary ACTH Hypersecretion; Prognosis; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2015 |
Evaluation of baseline cortisol concentration to monitor efficacy of twice-daily administration of trilostane to dogs with pituitary-dependent hyperadrenocorticism: 22 cases (2008-2012).
Topics: Adrenocorticotropic Hormone; Animals; Comorbidity; Dihydrotestosterone; Dog Diseases; Dogs; Enzyme Inhibitors; Female; Hydrocortisone; Male; Pituitary ACTH Hypersecretion; Retrospective Studies | 2016 |
Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Carbenoxolone; Dihydrotestosterone; Dog Diseases; Dogs; Female; Glucocorticoids; Hydrocortisone; Male; Pituitary ACTH Hypersecretion; Pituitary Gland | 2016 |
Clinical Relationship between Cholestatic Disease and Pituitary-Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series.
Topics: Adrenocorticotropic Hormone; Animals; Body Weight; Dihydrotestosterone; Dog Diseases; Dogs; Female; Gallbladder Diseases; Hydrocortisone; Male; Mucocele; Pituitary ACTH Hypersecretion; Retrospective Studies | 2017 |
Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Dihydrotestosterone; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Pituitary ACTH Hypersecretion; Pituitary-Adrenal System; Renin; Retrospective Studies; Treatment Outcome | 2010 |
Hypophysectomy for a dog with coexisting Cushing's disease and diabetes mellitus.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenocorticotropic Hormone; Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Dihydrotestosterone; Dogs; Dose-Response Relationship, Drug; Hypoglycemic Agents; Hypophysectomy; Insulin; Male; Pituitary ACTH Hypersecretion; Pituitary Gland | 2010 |